Smartphone mood tracking may predict Post-Stroke depression

NCT ID NCT04043052

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether daily mood check-ins via a mobile app could help predict and prevent depression in people who recently had a stroke. Over 400 participants used the app for three months while researchers tracked their emotional symptoms. The goal was to see if this kind of monitoring could identify those at risk early, so doctors could step in sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ecological Momentary Assessment (EMA) via mobile app
What this could lead to: If successful, this approach could help doctors identify stroke patients at high risk for depression early and offer timely support.
What could go wrong: This is an observational study, not a treatment trial. It tests monitoring, not prevention, so it may not directly reduce depression rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder hemorrhagic stroke ischemic stroke stroke disorder transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION STROKE

Contacts and locations

Locations

Assistance Publique Hopitaux de Paris - Groupe Hospitalier Paris Saint Joseph

Paris, 75 014, France
CHRU de Brest

Brest, 29 609, France
CHU Dijon Bourgogne

Dijon, 21 079, France
CHU de Bordeaux

Bordeaux, 33 076, France
CHU de Montpellier

Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.